Tiwari Pharma Private Limited
About Tiwari Pharma Private Limited
Data last updated:
Tiwari Pharma Private Limited is a private limited company based in Baddi, Himachal Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24304HP2018PTC007271. Its GSTIN is 02AAHCT0752E1ZT (Himachal Pradesh). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Dhirendra Kumar Tiwari and Dilip Kumar Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at SCO.5 Opposite D.S.K. Dharam Kanta Sai Road, Baddi, Himachal Pradesh, India – 173205.
As per the financials filed for FY 2024, the company reported a revenue of ₹561.28 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹9.73 Cr (net margin 1.7%) and EBITDA of ₹14.66 Cr (EBITDA margin 2.6%).
As per MCA filings, the company has open charges of ₹51 Cr and satisfied charges of ₹15.25 Cr on record. Court records list 23 cases involving the company, including 23 filed by the company; 14 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Tiwari Pharma Private Limited's registered office is in Baddi, Himachal Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSCO.5 Opposite D.S.K. Dharam Kanta Sai Road, Baddi, Himachal Pradesh, India – 173205
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Tiwari Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Tiwari Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Tiwari Pharma Private Limited, buy the company report.
Financials of Tiwari Pharma Private Limited
FY 2024 filings availableTiwari Pharma Private Limited reported revenue of ₹561.28 Cr (up 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 5% in the latest year. EBITDA rose 23% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹561.28 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.66 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.73 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.6% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tiwari Pharma Private Limited, buy the company report.
Board of directors of Tiwari Pharma Private Limited
Tiwari Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhirendra Kumar Tiwari | Director | 17 Dec 2018 | 7 Years 10 Months | Current |
| Dilip Kumar Tiwari Also directs: Sucantis Healthcare Private Limited, Capsules Centre Private Limited, PRJ Print and Pack Private Limited and 4 more | Director | 17 Dec 2018 | 7 Years 10 Months | Current |
| Ajay Kumar Tiwari | Director | 17 Dec 2018 | 7 Years 10 Months | Current |
Peer comparison
Tiwari Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vapco Engineers Private Limited | ₹569.46 Cr (FY 2025) | 2.0% | Navi Mumbai, Maharashtra, India | |||
| Asahi Songwon Colors Limited | ₹566.4 Cr (FY 2025) | 32.0% | Ahmedabad, Gujarat, India | |||
| Bajaj Healthcare Limited | ₹562.01 Cr (FY 2025) | 17.0% | Thane, Maharashtra, India | |||
| G S Pharmbutor Private Limited | ₹561.56 Cr (FY 2025) | 6.0% | Rudrapur, Uttarakhand, India | |||
| Prathista Industries Limited | ₹561.42 Cr (FY 2024) | 28.0% | Yadadri Bhongir, Telangana, India | |||
| Tiwari Pharma Private Limitedthis company | ₹561.28 Cr (FY 2024) | ₹9.73 Cr | 1.7% | 5.0% | Baddi, Himachal Pradesh, India | |
| Ind Swift Limited | ₹560.24 Cr (FY 2024) | 33.0% | Chandigarh, India | |||
| Tanfac Industries Limited | ₹559.94 Cr (FY 2025) | 45.0% | Cuddalore, Tamil Nadu, India | |||
| Sheenlac Paints Limited | ₹559.52 Cr (FY 2025) | -3.0% | Chennai, Tamil Nadu, India | |||
| Hindustan Organic Chemicals Limited | ₹558.62 Cr (FY 2025) | -22.0% | Kunnathunad, Kerala, India | |||
| Finorchem Limited | ₹558.51 Cr (FY 2025) | 3.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Tiwari Pharma Private Limited, buy the company report.
Auditor
Tiwari Pharma Private Limited is audited by Ashwani & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ashwani & Associates | FY 2024 | 000497N |
Shareholding
The shareholding of Tiwari Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Tiwari Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Aug 2023 | 100814459 | Hdfc Bank Limited | ₹51 Cr | Open | |
| 27 Feb 2023 | 100690256 | Axis Bank Limited | ₹13 Cr | Satisfied | |
| 19 May 2020 | 100343225 | Others | ₹2.25 Cr | Satisfied |
To see the full charge records of Tiwari Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Tiwari Pharma Private Limited has 23 court cases on record: 23 filed by Tiwari Pharma. 14 cases are pending and 9 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 23 | 0 | 14 |
Cases on record (5 of 23)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Ms Epick Drugs Pvt Ltd | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against M/S Amentis Biotech Private Limited | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against M/S Cosmas Pharmacls Ltd. and 5 others | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Ms Celebrity Biopharma Limited | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Habitare Pharma Pvt Ltd and 3 others | Disposed |
To see the full case history of Tiwari Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tiwari Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Tiwari Pharma has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAHCT0752E1ZT | Himachal Pradesh | Active | 10 Nov 2021 |
| 05AAHCT0752E1ZN | Uttarakhand | Active | 25 Nov 2019 |
| 01AAHCT0752E1ZV | Jammu and Kashmir | Active | 10 Mar 2025 |
To see the full GST registrations and return filing status of Tiwari Pharma Private Limited, buy the company report.
Recent activity
Tiwari Pharma Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Ajay Kumar Tiwari was appointed as Director on 17 Dec 2018.
Frequently asked questions
Tiwari Pharma is an active private limited company based in Baddi, Himachal Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 December 2018 (8+ years old) and is registered under CIN U24304HP2018PTC007271.
Tiwari Pharma has 3 current directors:
- Dhirendra Kumar Tiwari - Director
- Dilip Kumar Tiwari - Director
- Ajay Kumar Tiwari - Director
The latest financial statements of Tiwari Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Tiwari Pharma is 02AAHCT0752E1ZT, registered in Himachal Pradesh. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 05AAHCT0752E1ZN (Uttarakhand), 01AAHCT0752E1ZV (Jammu and Kashmir).
The CIN (Corporate Identification Number) of Tiwari Pharma is U24304HP2018PTC007271. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tiwari Pharma has 23 court cases on record: 23 filed by the company. 14 are pending.
Tiwari Pharma was incorporated on 17 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of Tiwari Pharma by revenue are Vapco Engineers Private Limited, Asahi Songwon Colors Limited, Bajaj Healthcare Limited, G S Pharmbutor Private Limited, Prathista Industries Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ajay Kumar Tiwari was appointed as Director on 17 Dec 2018. Dhirendra Kumar Tiwari was appointed as Director on 17 Dec 2018. Dilip Kumar Tiwari was appointed as Director on 17 Dec 2018.
The registered office of Tiwari Pharma is at SCO.5 Opposite D.S.K. Dharam Kanta Sai Road, Baddi, Himachal Pradesh, India – 173205.
Tiwari Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.